Picture of Newron Pharmaceuticals SpA logo

NWRN — Newron Pharmaceuticals SpA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Europe Research Roundup: GlaxoSmithKline, Prudential, Nordea

Jan 24 (Reuters) - Securities analysts revised their ratings and price targets on several 
European companies, including Beazley, Nordea and Talktalk Telecom, on Tuesday.  
     
    HIGHLIGHTS 
     * GlaxoSmithKline  GSK.L : Leerink raises target price to 1912p from 1882p;market perform      
  
     * Nordea  NDA.ST : RBC raises to outperform from sector perform 
     * Prudential Plc  PRU.L : Morgan Stanley raises price target to 1959p from 1837p 
     * SEB AB  SEBa.ST : RBC cuts to underperform from sector perform 
       
Following is a summary of research actions on European companies reported by Reuters on Tuesday. 
Stock entries are in alphabetical order.    
     
     * Allianz SE  ALVG.DE : Barclays cuts target price to 148 euros from 150 euros;underweight 
     * Beazley Plc  BEZG.L : JP Morgan raises price target to 460p from 455p; rating overweight 
     * BTG Plc  BTG.L : Jefferies cuts price target to 775p from 860p; rating buy 
     * GlaxoSmithKline  GSK.L : Leerink raises target price to 1912p from 1882p; market perform 
     * Handelsbanken  SHBa.ST : RBC raises price target to Sek 130 from Sek 125; sector perform 
     * Ipsen SA  IPN.PA : Jefferies raises price target to eur 100.00 from eur 80.00 
     * Newron Pharmaceuticals  NWRN.S : Jefferies starts with buy rating; Sfr 40 price target 
     * Nordea  NDA.ST : RBC raises price target to Sek 110 from Sek 100 
     * Nordea  NDA.ST : RBC raises to outperform from sector perform 
     * Prudential Plc  PRU.L : Morgan Stanley raises price target to 1959p from 1837p 
     * SEB AB  SEBa.ST : RBC cuts to underperform from sector perform 
     * Swedbank  SWEDa.ST : RBC raises price target to Sek 235 from Sek 230; rating outperform 
     * Talktalk Telecom Group  TALK.L : Jefferies cuts target to 125p from 140p; underperform 
     * Unicredit SpA  CRDI.MI : Barclays adjusts target price to 20 euros from 2 euros 
  
  
 
 (Compiled by Bengaluru Newsroom) 
 ((Bengaluru Newsroom: +1 646 223 8780)) 
 
Keywords: RESEARCH EUROPE/

Recent news on Newron Pharmaceuticals SpA

See all news